Has Raymond Kimball received payments from drug or device companies?

Yes. Drug and device makers reported $5,123 in general payments to Raymond Kimball across 269 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Raymond Kimball did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Raymond Kimball come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Raymond Kimball

Psychiatry · Anderson, SCNPI 1285668608

Payments from drug & device makers

$5,123in general payments, 2019–2025

Across 269 payments — averaging $19.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Teva Pharmaceuticals USA, Inc.$2K
Otsuka America Pharmaceutical, Inc.$616
Johnson & Johnson$592
E.r. Squibb & Sons, L.L.C.$354
Neurocrine Biosciences, Inc.$301
Sunovion Pharmaceuticals Inc.$292
plus $939 from 7 others

What the payments were for

Food & beverage$4,70292%
Education$4218%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Teva Pharmaceuticals USA, Inc.	119	$2,028
Otsuka America Pharmaceutical, Inc.	30	$616
Johnson & Johnson	31	$592
E.r. Squibb & Sons, L.L.C.	13	$354
Neurocrine Biosciences, Inc.	13	$301
Sunovion Pharmaceuticals Inc.	13	$292
Alkermes, Inc.	11	$236
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	6	$209
AbbVie(2 entities)	13	$187
Vanda Pharmaceuticals Inc.	7	$119
Indivior Inc.	8	$101
Lundbeck LLC	4	$63
Axsome Therapeutics, Inc.	1	$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,123 in reported general payments places this provider in the 85th percentile of 624 psychiatry providers in South Carolina.

See all psychiatry providers in South Carolina →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Invega SustennaPaliperidone Palmitate	34	$104,899
Abilify MaintenaAripiprazole	11	$30,214
Aripiprazole	22	$3,549
Paliperidone ErPaliperidone	12	$1,790
Clozapine	13	$1,492
Duloxetine Hcl	19	$873
Hydroxyzine Pamoate	26	$824
Benztropine Mesylate	37	$656
Trazodone Hcl	56	$644
Buspirone Hcl	29	$626
AmantadineAmantadine Hcl	11	$578
Bupropion XlBupropion Hcl	25	$559
Doxepin Hcl	23	$541
Mirtazapine	25	$463
Risperidone	27	$396

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Johnson & JohnsonInvega Sustenna	$592	$104,89934 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena	$616	$30,21411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 624 psychiatry providers in South Carolina.

Other psychiatry in Anderson

Jacobo MintzerCharleston$4.9M
Paul RobbinsSummerville$1.2M
Brittany AlbrightMount Pleasant$691K
Eduardo CifuentesCharleston$675K
Veronica RidpathFlorence$364K
Mark GeorgeCharleston$332K
Jagdish ShahRock Hill$320K
Ricardo FermoCharleston$262K
John DewittAiken$221K
Thomas UhdeCharleston$205K

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →